Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer
β Scribed by Hee Eun Lee; Min A Kim; Byung Lan Lee; Woo Ho Kim
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 219 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background and Objectives
We designed this study to assess the biologic significance of Kiβ67 proliferation index (PI) in gastric cancer.
Methods
Gastric cancer tissue from 245 patients were immunostained for Kiβ67. Kiβ67 PI was defined as the percentage of tumor cells positive for Kiβ67. In addition, we have previously evaluated the expressions of nine epithelial mesenchymal transition (EMT)βrelated proteins. The relationship between Kiβ67 PI and clinicopathologic parameters, patient survival, and EMT data were sought.
Results
Low Kiβ67 PI was correlated with poorly differentiated histology (Pβ=β0.034), an advanced T stage (Pβ<β0.001), and lymph node metastasis (Pβ=β0.011). Also, the low PI group was found to have a significantly worse prognosis than the high PI group (Pβ=β0.003, logβrank test). Multivariate analysis revealed that Kiβ67 PI remained as an independent prognostic factor (hazard ratio (95% CI)β=β0.670 (0.450β0.999)). Furthermore, greater expressional changes of EMTβrelated proteins were found to be significantly associated with low Kiβ67 PI (Pβ=β0.025).
Conclusions
These findings suggest that Kiβ67 PI is an effective tool for predicting survival in gastric cancer. In addition, we found that an invasive property presented as EMTβrelated protein expressional changes was inversely correlated with a proliferative activity in gastric cancer. J. Surg. Oncol. 2010;102:201β206. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract In a longβterm followβup study, prolactin levels were measured in 149 patients with advanced metastatic breast cancer. Control groups included 221 patients with primary operable breast cancer and 150 women with benign breast disease. Hyperprolactinemia (>1,000 mlU/l; HYPRL) occurs in 44
## Abstract Accurate prognostic parameters in prostate biopsies are needed to better counsel individual patients with prostate cancer. We evaluated the prognostic impact of morphologic and immunohistochemical parameters in preoperative prostate cancer biopsies. A consecutive series of prostate biop